Moody's and s&p change fresenius medical care's rating outlook to stable

The change of the rating outlook reflects the company's progress in restoring credit metrics and the commitment to maintain its investment grade rating fme is expected to maintain its good growth momentum, while continuing to improve operational performance on the back of its strong transformation progress solid deleveraging prospects bad homburg, germany , may 23, 2024 /prnewswire/ -- fresenius medical care (fme), the world's leading provider of products and services for individuals with renal diseases, today received from s&p global, a leading rating agency, the change of its rating outlook to stable from negative (bbb-, stable outlook). moody's changed the credit rating outlook from negative to stable on may 17 (baa3, stable outlook).
FMS Ratings Summary
FMS Quant Ranking